FEB 17, 2020 12:36 PM PST

Listening in on cancer cells

Research published today in Nature Methods reports a new technique of “listening” to cancer cells. While it may sound odd (no pun intended), this innovative method could help scientists understand why certain tumors respond to certain treatments and ultimately develop improved cancer drugs.

The study, led by Dr. Chris Tape from UCL, utilized organoids to search for specific signaling molecules. Organoids are small self-organizing tumors grown in the lab surrounded by other cells, such as immune cells and connective tissue. They are more effective at predicting responses to cancer drugs in the human body than cells grown in a culture because they mimic cancer’s behavior in humans. The study wanted to see if these organoids were sending messages to neighboring cells to instruct them how to behave.

"Organoids are already revolutionizing cancer research by allowing us to test whether experimental new drugs are effective on lifelike models of tumors. But crucially, this new technique helps scientists to understand why a treatment works or not, by revealing in unprecedented detail how cells are talking to each other," said Dr. Tape.

Dr. Emily Armstrong, a research information manager at Cancer Research UK, said: "Having a better understanding of this complex communication between cancer cells and other types of cells that make up a tumor could reveal secrets of how cancer comes back after treatment and spreads around the body.

In fact, one way that the researchers foresee their findings becoming commonplace in the future is through the development of tumor replicas. For instance, if scientists are able to create replicas of tumors on the cellular level that will communicate with other cells and respond to certain treatments the same way they would within an individual’s body, we will have taken a huge step forward in treating cancer.

Such information is imperative in order to choose the most effective treatments for individuals. “While this technique is in the early stages of development right now, in the future we may be able to grow replicas of individual patients' tumors, to identify early signs that a drug won't work for them so we can personalize their treatment plan. We hope this could one day help more people to survive cancer," said Dr. Armstrong.

Sources: Eureka Alert, Nature Methods, UK Cancer Research

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
SEP 09, 2021
Cancer
Can a Mole Fight Melanoma?
SEP 09, 2021
Can a Mole Fight Melanoma?
About 30% of melanoma cases arise from an existing nevus.  More commonly known as moles, Nevi are skin growths that ...
SEP 28, 2021
Immunology
Cell Therapy Scrubs Tumors, Spares Transplanted Organs
SEP 28, 2021
Cell Therapy Scrubs Tumors, Spares Transplanted Organs
Hepatitis B infections have created a ‘silent epidemic’—infected people don’t display any sympto ...
OCT 14, 2021
Clinical & Molecular DX
Cancer-Sniffing Worms: The Future of Diagnostics?
OCT 14, 2021
Cancer-Sniffing Worms: The Future of Diagnostics?
Researchers have unlocked a way of sniffing out cancer in patients with very-early-stage pancreatic cancer. This time, i ...
OCT 26, 2021
Immunology
Two Different Arms, Twice the Cancer-Killing Potential?
OCT 26, 2021
Two Different Arms, Twice the Cancer-Killing Potential?
Our immune system has developed an arsenal of sophisticated molecular weapons to defend us against the continuous barrag ...
NOV 25, 2021
Cancer
Could an Anti-Cancer Drug Treat Diabetes?
NOV 25, 2021
Could an Anti-Cancer Drug Treat Diabetes?
Diabetes and cancer are two common diseases that share many similar risk factors. People with diabetes are also at& ...
DEC 02, 2021
Cancer
A New Method to Enhance Immunotherapy in Mouse Tumors
DEC 02, 2021
A New Method to Enhance Immunotherapy in Mouse Tumors
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer, accounting for about 90% of pancre ...
Loading Comments...